期刊文献+

重症SARS患者的临床特点与治疗经验 被引量:2

The clinical characteristic features and the experience of treatment of the critical SARS patients
下载PDF
导出
摘要 目的 :探讨重症SARS患者的临床特点及治疗上的特殊性。方法 :回顾性分析我院SARS ICU收治的 36例重症SARS患者的临床资料。结果 :36例重症SARS患者中 ,18例 (5 0 % )年龄 >5 0岁 ,5 8.3%的患者有家庭聚集性发病倾向 ,6 1.1%的患者有明确的基础疾病 ,97.2 %的患者发病初期有明确的高热症状 (≥ 38℃ ) ,83.3%、72 .2 %、5 5 .6 %及 4 4 .4 %的患者分别存在淋巴细胞亚群、心肌酶、肝功及血糖的异常 ,77.8%的患者有X线胸片双肺同时受累的改变 ,86 .1%的患者治疗中使用了肾上腺糖皮质激素 ,30 .6 %及 13.9%的患者救治过程中分别使用了无创或有创通气方式 ,4 1.7%的患者治疗过程中出现了不同程度的合并症。结论 :重症SARS患者病情复杂 ,治疗难度大 ,及早联合治疗能收到很好的临床效果。 Objective:To explore the clinical characteristic features and the effective treatments of the critical SARS patients in ICU. Methods: To analyze the clinical documents of 36 SARS patients in ICU of our hospital by using Retrospective survey study. Results:In all of the 36 SARS patients in ICU, the age of 18 cases (50%) were over 50 years, 58.3% of the patients belong to family collective outbreak, 61.1% of the patients categorically had basic diseases, 97.2% of the patients began with obvious high fever (KT≥38℃). 83.3%, 72.2%, 55.6% and 44.4% of the patients were with abnormal T- lymphocyte subgroup, myocardial enzyme, liver function and blood glucose, respectively. 77.8% of the patients had showed pulmonary involvement on chest X-ray film. Different dosage of glucocorticosteroids had been used for 86.1% of the patients in the process of treatment. Non-invasive positive pressure ventilation (NIPPV) and the invasive ventilation (IV) were used for 30.6% and 13.9% of the SARS patients, respectively, in the process of treatment. Complications occurred in 41.7% of the patients during the process of the treatment. Conclusion: The condition of the critical SARS patients were complicated and their treatment was difficult. A good clinical result can be achieved if the combined treatment has been used early.
出处 《中日友好医院学报》 2003年第4期195-198,共4页 Journal of China-Japan Friendship Hospital
关键词 重症型 SARS 临床特点 联合治疗 合并症 机械通气 severe acute respiratory syndrome critical clinical characteristic feature treatment
  • 相关文献

参考文献9

  • 1徐小元,王广发,陆海英,李海潮,霍娜,王军,聂立功,阙呈立.SARS临床分期及各期治疗要点的经验总结[J].北京大学学报(医学版),2003,35(B05):5-6. 被引量:29
  • 2王广发,徐小元.SARS诊断与治疗中有关问题的思考[J].北京大学学报(医学版),2003,35(B05):2-4. 被引量:15
  • 3中华人民共和国卫生部.重症非典型肺炎诊断标准.http://www.moh.gov.cn.,2003-05-06.
  • 4中国医学论坛报.SARS诊断学研究.http://www.cmt.com.cn.,2003-07-01.
  • 5赵子文 张复春 许敏 等.2003年春广州地区传染性非典型肺炎暴发流行190例临床分析.http://www.cma.org.cn,2003-05-19.
  • 6Lotetta.K-Y.So Arthur CW Lau.抗生素、利巴韦林和甲泼尼龙联合治疗SARS的标准方案.http://www.cmt.com.cn.,2003-07-01.
  • 7中国医学论坛报.SARS治疗学研究.http://www.cmt.com.cn.,2003-07-01.
  • 8譬叁县基和国卫生部.SARS患者相关精神障碍的预防及推荐治疗原则(草案).http:∥www.moh.gov.cn.,2003-06-03.
  • 9Drosten C, Gather S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome[J]. N Engl J Med,2003.348:1967-1976.

二级参考文献9

  • 1.传染性非典型肺炎临床诊断标准(试行).[S].中华人民共和国卫生部,2003—05—03..
  • 2Lee N, Hui D, Wu A, et al. A major outbreak of Severe Acute Respiratory Syndrome in Hong Kong[J]. N Engl J Med, 2003,348:1986-1994
  • 3Chan-Yeung M, Yu WC. Outbreak of severe acute respiratory syndrome in Hong Kong special administrative region: case report[J]. BMJ, 2003,326(7349):850-852
  • 4Lesur O, Berthiaume Y, Blaise G, et al. Acute respiratory distress syndrome: 30 years later[J]. Can Respir J, 1999,6(1):71-86
  • 5李楠 马靖 李海潮 等.8例传染性非典型肺炎死亡分析[J].北京大学学报:医学版,2003,.
  • 6李楠,马靖,聂立功,李海潮,阙呈立,高志东,王广发,徐小元,陆海英,王贵强.肾上腺糖皮质激素治疗SARS的回顾性分析[J].北京大学学报(医学版),2003,35(B05):16-18. 被引量:22
  • 7徐国宾,陆海英,李杰,李勇华,冯珍如,霍娜,王广发,赵振东,张国华,闫存玲,李海霞,高晓明,徐小元,王贵强,庄辉.SARS患者及其医护人员血中特异IgG抗体变化规律的初步研究[J].北京大学学报(医学版),2003,35(B05):23-25. 被引量:26
  • 8马靖,李楠,阙呈立,李海潮,聂立功,王广发,高志东,王仁贵,徐小元,陆海英,王贵强.SARS胸片特点及其动态演变[J].北京大学学报(医学版),2003,35(B05):38-40. 被引量:7
  • 9李海潮,聂立功,王广发,阙呈立,马靖,李楠,赵志杰,高志东,徐小元,陆海英.无创正压通气治疗SARS的临床观察[J].北京大学学报(医学版),2003,35(B05):41-43. 被引量:13

共引文献41

同被引文献20

  • 1周同 邓伟吾.SARS肺损伤与抗白细胞粘附防治的思路IN][J].中国医学论坛报(SARS研究进展),2003,5(2):16-16.
  • 2中华人民共和国卫生部.重症非典型性肺炎诊断标准[N].中国医学论坛报,SARS研究进展,2003,5(第2辑):44.
  • 3Siazek TG,Erdman D,Smith CS,et al.A novel coronavirus associated with severe acute respiratory syndrome[J].N Eng J Med,2003,348∶1953~1966.
  • 4Holmes KV,Enjuanes L.The SARS Coronavirus∶a postyenomic Era[J]. Science,2003,300∶1377~1378.
  • 5Marra MA,Jones SJ,Astell CR,et al.The genome sequence of the SARS-associatedcoronavirus[J].Science,2003,300∶1399~1404.
  • 6Krueger DK,Kelly SM,Lewicki ND,et al.Variations in disparate regions of the murine coronavirus spike protein impact the initiation of membrane fusion[J]. J virol,2001,75(6)∶2792~2802.
  • 7Peiris JM,Chu CM,Cheng VC,et al.Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia:aprospective study[J].Lancet,2003,361∶1767~1772.
  • 8郎振为,张立洁,张世杰,等.严重呼吸综合征3例尸解病理分析[J].2003中华医学会系列杂志SARS研究论文集,2003.117~120.
  • 9丁彦青,王惠君,申洪,等.严重呼吸综合征临床病理学观察[J].2003中华医学会系列杂志SARS研究论文集,2003.111~116.
  • 10Nicholls JM,Poon LM,Lee KC,et al.Lung pathology of fatal severe acute respiratory Syndrome[J].Lancet,2003,361∶1773~1778.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部